Melanoma
News
MULTIMEDIA: Vemurafenib -- Melanoma Drug Cuts Death Risk
News
Melanoma Heads Down the Genetic Pathway
News
Laser Therapy of Nonmelanoma Cancers Continues to Grow
Video
Video of the Week: More Melanoma Treatments on the Way?
News
Real-Time Monitoring of Melanoma Markers Predicts Relapse
News
Melanoma Treatment Ipilimumab Approved Europe-Wide
News
Cancer-Protective Effects Seen for Type IV Allergies
Major Finding: The investigators found an inverse association between diagnosed contact allergy and nonmelanoma skin cancer (OR, 0.82) along with...
News
Melanoma Patients Respond to Combo of BRAF and MEK Inhibitors
Major Finding: The objective response rate ranged from 50% to 77%, depending on doses, among patients who had not previously received any BRAF...
News
AAD President Commends FDA on Sunscreen Regulations
News
Ipilimumab Added to Dacarbazine Prolongs Survival for Metastatic Melanoma
Major Finding: Nearly 21% of 250 metastatic melanoma patients who underwent first-line treatment with ipilimumab (Yervoy, Bristol-Myers Squibb) in...
News
Ipilimumab Added to Dacarbazine Prolongs Survival for Metastatic Melanoma
Major Finding: Nearly 21% of 250 metastatic melanoma patients who underwent first-line treatment with ipilimumab (Yervoy, Bristol-Myers Squibb) in...